Search research articles
Contact Us
Filters
Showing results (111-120 of 159) with videos related to
Page
of 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 19, 2025
Investigating Early Kinetics in Plasma ctDNA and Peripheral T Cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck Cancer
Enrique Sanz-Garcia, Shirin Soleimani, Jeff P Bruce, et al.
The Lancet. Oncology
|
March 20, 2026
A practical toolkit with recommendations for analysing and visualising patient-reported outcomes in early phase dose-finding oncology trials (OPTIMISE-AR)
Emily Alger, Antoine Regnault, Amylou C Dueck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 26, 2023
Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors
Maria Vieito, Victor Moreno, Anna Spreafico, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 7, 2019
Radiologic Extranodal Extension Portends Worse Outcome in cN+ TNM-8 Stage I Human Papillomavirus-Mediated Oropharyngeal Cancer
Astrid Billfalk-Kelly, Eugene Yu, Jie Su, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 23, 2019
Impact of cisplatin dose and smoking pack-years in human papillomavirus-positive oropharyngeal squamous cell carcinoma treated with chemoradiotherapy
Marc Oliva, Shao Hui Huang, Wei Xu, et al.
Cancer
|
June 2, 2020
Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal
Shao Hui Huang, Brian O'Sullivan, Jie Su, et al.
British Journal of Cancer
|
May 7, 2024
Prospective manipulation of the gut microbiome with microbial ecosystem therapeutic 4 (MET4) in HPV-related locoregionally-advanced oropharyngeal cancer squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation: ROMA2 study
Marc Oliva, Alya Heirali, Geoffrey Watson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 13, 2014
A phase I monotherapy study of RG7212, a first-in-class monoclonal antibody targeting TWEAK signaling in patients with advanced cancers
Ulrik N Lassen, Didier Meulendijks, Lilian L Siu, et al.
British Journal of Cancer
|
March 22, 2021
Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study)
Marc Oliva, Pierre H H Schneeberger, Victor Rey, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
October 21, 2023
Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)
Sofia Genta, Katherine Lajkosz, Noelle R Yee, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 159) with videos related to
Sort By:
Page
of 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 19, 2025
Investigating Early Kinetics in Plasma ctDNA and Peripheral T Cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck Cancer
Enrique Sanz-Garcia, Shirin Soleimani, Jeff P Bruce, et al.
The Lancet. Oncology
|
March 20, 2026
A practical toolkit with recommendations for analysing and visualising patient-reported outcomes in early phase dose-finding oncology trials (OPTIMISE-AR)
Emily Alger, Antoine Regnault, Amylou C Dueck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 26, 2023
Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors
Maria Vieito, Victor Moreno, Anna Spreafico, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 7, 2019
Radiologic Extranodal Extension Portends Worse Outcome in cN+ TNM-8 Stage I Human Papillomavirus-Mediated Oropharyngeal Cancer
Astrid Billfalk-Kelly, Eugene Yu, Jie Su, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 23, 2019
Impact of cisplatin dose and smoking pack-years in human papillomavirus-positive oropharyngeal squamous cell carcinoma treated with chemoradiotherapy
Marc Oliva, Shao Hui Huang, Wei Xu, et al.
Cancer
|
June 2, 2020
Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal
Shao Hui Huang, Brian O'Sullivan, Jie Su, et al.
British Journal of Cancer
|
May 7, 2024
Prospective manipulation of the gut microbiome with microbial ecosystem therapeutic 4 (MET4) in HPV-related locoregionally-advanced oropharyngeal cancer squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation: ROMA2 study
Marc Oliva, Alya Heirali, Geoffrey Watson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 13, 2014
A phase I monotherapy study of RG7212, a first-in-class monoclonal antibody targeting TWEAK signaling in patients with advanced cancers
Ulrik N Lassen, Didier Meulendijks, Lilian L Siu, et al.
British Journal of Cancer
|
March 22, 2021
Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study)
Marc Oliva, Pierre H H Schneeberger, Victor Rey, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
October 21, 2023
Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)
Sofia Genta, Katherine Lajkosz, Noelle R Yee, et al.
Page
of 16